Sibling 1 | Sibling 2 | Sibling 3 | Sibling 4 | Sibling 5 | Sibling 6 | |
---|---|---|---|---|---|---|
Mutation | MMACHC, c.394C>T Homozygous | MMACHC, c.394C>T Heterozygous | MMACHC, c.394C>T Homozygous | MMACHC, c.394C>T Heterozygous | MMACHC, c.394C>T Homozygous | MMACHC, c.394C>T Homozygous |
CD320, c.262_264del Heterozygous | CD320, c.262_264del Heterozygous | CD320, c.262_264del Heterozygous | CD320, c.262_264del Heterozygous | CD320, c.262_264del Heterozygous | ||
Gender | Female | Female | Female | Male | Male | Male |
Current age | 11 years | 8 years | 7 years | 5 years | 3.5 years | 3.5 years |
Age at onset | 6 years | 3 months | 6.5 years | 3.5 years | 3.5 years | 3.5 years |
1st symptoms | Behavior changes | Developmental milestones not achieved | Psychiatric changes | Learning dis ability | Loss of motor and language skills | Normal |
Condition at presentation | No speech, no socialization Lost ambulation Poor appetite Bed ridden | Global developmental delay Only hearing and vision were preserved | Phobias Bouts of cries and laughter | Below average at studies, take too long to learn simple task | Bed ridden Lost ambulation Socialization Speech | Normal |
Examination at presentation | Conscious Tone increased Reflexes brisk Plantars upgoing | Conscious Can fix gaze and localize sound Tone increased, reflexes brisk, plantars b/l up going | Conscious Power tone and reflexes were normal | Conscious Power tone and reflexes were normal | Conscious Normal power, tone and reflexes | Conscious Normal power tone and reflexes |
Failure to thrive (z score) | Wt; 46 Ht;160 − 1 SD | 16 kg 113 cms − 1 SD | 12 kg 114 cms − 4 SD | 16 kg 107 cms − 1 SD | 10 kg 91 cms − 2 SD | 10 kg 96 cms − 3 SD |
OFC | 53 cms | 45 cms | 46 cms | 49 cms | 46 cms | 46 cms |
Megaloblastic anemia | Absent | Absent | Absent | Absent | Absent | Absent |
Serum B12 level | Normal | Normal | Normal | Normal | Normal | Normal |
Serum homocysteine level | 165 umol/l | 98 umol/l | 102 umol/l | 65 umol/l | 156 umol/l | 70 umol/l |
Serum methionine level | 45 umol/l | 29 umol/l | 41 umol/l | 35 umol/l | 51 umol/l | 29 umol/l |
Urinary GCMS | Raised MMA | Raised MMA | Raised MMA | Raised MMA | Raised MMA | Raised MMA |
Quantitative urinary mma (before tx) | 7100 nmol/l | 6895 nmol/l | 7305 nmol/l | 7100 nmol/l | 6721 nmol/l | 7174 nmol/l |
Quantitative urinary mma (after tx) | 170 nmol/l | 158 nmol/l | 145 nmol/l | 168 nmol/l | 225 nmol/l | 198 nmol/l |
Brain imaging | Fig. 1a | Fig. 1b | Normal | Normal | Fig. 1c | Normal |
Clinical condition after 6 months of treatment | She has become social and interactive, fluent speech walks with ataxic gait | She has started sitting with support, responds to commands and recognizes faces | Little improvement in symptoms | Same | Started walking, active, alert and plays with siblings |